GSK3196165
Drug timelines are a Plus or Pro feature.
8 regulatory and trial events tracked for GSK3196165, covering 2018-11-16 to 2024-02-07. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) [Phase 3]